Tim Kaine actually said...
If we could do that and we could reduce the significant amount that we are paying in rebates to intermediaries who are not passing those rebates on to lower out-of-pocket costs, speaking on behalf of Bristol-Myers Squibb, we could work almost immediately to begin to bring down list prices.
Context
Kaine highlights potential for immediate price reductions through reform.
02/08/2024